James Loch
10Patents
3h-index
22Co-inventors
60Inventor score
Filing activity: Dec 23, 1999 → May 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6995167B2 | Arylkylamine spirofuropyridines useful in therapy | Human Necessities | 14 | Expired |
| US7196096B2 | Substituted amines of spirofuropyridines useful in therapy | Human Necessities | 12 | Expired |
| US10399951B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 4 | Active |
| US10472342B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US10450286B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US10457655B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 3 | Active |
| US10995078B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 0 | Active |
| US10450251B2 | Process for the preparation of 3-substituted cannabinoid compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US10828315B2 | Targeted therapeutics | Human Necessities | 0 | Active |
| US10800750B2 | Compounds and compositions for inhibition of FASN | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.